Efficacy and safety of microvascular decompression with or without partial sensory rhizotomy: a comprehensive meta-analysis and systematic review in treating trigeminal neuralgia
- PMID: 38787487
- DOI: 10.1007/s10143-024-02463-4
Efficacy and safety of microvascular decompression with or without partial sensory rhizotomy: a comprehensive meta-analysis and systematic review in treating trigeminal neuralgia
Abstract
Classical trigeminal neuralgia (TN), caused by vascular compression of the nerve root, is a severe cause of pain with a considerable impact on a patient's quality of life. While microvascular decompression (MVD) has lower recurrence rates when compared with partial sensory rhizotomy (PSR) alone, refractoriness can still be as high as 47%. We aimed to assess the efficacy and safety profile of MVD + PSR when compared to standalone MVD for TN. We searched Medline, Embase, and Web of Science following PRISMA guidelines. Eligible studies included those with ≥ 4 patients, in English, published between January 1980 and December 2023, comparing MVD vs. MVD + PSR for TN. Endpoints were pain cure, immediate post-operative pain improvement, long-term effectiveness, long-term recurrence, and complications (facial numbness, hearing loss, and intracranial bleeding). We pooled odds ratios (OR) with 95% confidence intervals with a random-effects model. I2 was used to assess heterogeneity, and sensitivity and Baujat analysis were conducted to address high heterogeneity. Eight studies were included, comprising a total of 1,338 patients, of whom 1,011 were treated with MVD and 327 with MVD + PSR. Pain cure analysis revealed a lower likelihood of pain cure in patients treated with MVD when compared to patients treated with MVD + PSR (OR = 0.30, 95% CI: 0.13 to 0.72). Immediate postoperative pain improvement assessment revealed a lower likelihood of improvement in the MVD group when compared with the MVD + PSR group (OR = 0.31, 95% CI: 0.10 to 0.95). Facial numbness assessment revealed a lower likelihood of occurrence in MVD alone when compared to MVD + PSR (OR = 0.08, 95% CI: 0.04 to 0.15). Long-term effectiveness, long-term recurrence, hearing loss, and intracranial bleeding analyses revealed no difference between both approaches. Our meta-analysis identified that MVD + PSR was superior to MVD for pain cure and immediate postoperative pain improvement for treating TN. However, MVD + PSR demonstrated a higher likelihood of facial numbness complications. Furthermore, identified that hearing loss and intracranial bleeding complications appear comparable between the two treatments, and no difference between long-term effectiveness and recurrence.
Keywords: Microvascular decompression; Partial sensory rhizotomy; Trigeminal neuralgia.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
The influence of prior percutaneous rhizotomy on outcomes following microvascular decompression for trigeminal neuralgia.J Neurosurg. 2023 Oct 20;140(4):1155-1159. doi: 10.3171/2023.8.JNS231345. Print 2024 Apr 1. J Neurosurg. 2023. PMID: 37862713
-
A Systematic Review of Repeat Microvascular Decompression for Recurrent or Persistent Trigeminal Neuralgia.World Neurosurg. 2022 Feb;158:226-233. doi: 10.1016/j.wneu.2021.11.129. Epub 2021 Dec 5. World Neurosurg. 2022. PMID: 34875391
-
Repeat Surgery for Recurrent or Refractory Trigeminal Neuralgia: A Systematic Review and Meta-Analysis.World Neurosurg. 2024 May;185:370-380.e2. doi: 10.1016/j.wneu.2024.02.097. Epub 2024 Feb 24. World Neurosurg. 2024. PMID: 38403014
-
Current advances in the surgical treatment of glossopharyngeal neuralgia.Neurosurg Rev. 2023 Feb 2;46(1):47. doi: 10.1007/s10143-023-01948-y. Neurosurg Rev. 2023. PMID: 36725770
-
Efficacy analysis of microvascular decompression and percutaneous balloon compression for trigeminal neuralgia secondary to vertebrobasilar dolichoectasia: a retrospective cohort study.Acta Neurochir (Wien). 2025 Aug 21;167(1):225. doi: 10.1007/s00701-025-06651-z. Acta Neurochir (Wien). 2025. PMID: 40836140 Free PMC article.
Cited by
-
Microsurgical outcomes for vestibular schwannomas associated with trigeminal neuralgia.Neurosurg Rev. 2025 Mar 27;48(1):329. doi: 10.1007/s10143-025-03483-4. Neurosurg Rev. 2025. PMID: 40140122
-
The progress in epidemiological, diagnosis and treatment of primary hemifacial spasm.Heliyon. 2024 Sep 30;10(19):e38600. doi: 10.1016/j.heliyon.2024.e38600. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39430510 Free PMC article. Review.
-
Pathophysiology and Management of Refractory Trigeminal Neuralgia.Curr Neurol Neurosci Rep. 2024 Dec 12;25(1):10. doi: 10.1007/s11910-024-01387-2. Curr Neurol Neurosci Rep. 2024. PMID: 39665844 Review.
References
-
- Dieleman JP, Kerklaan J, Huygen FJPM, Bouma PAD, Sturkenboom MCJM (2008) Incidence rates and treatment of neuropathic pain conditions in the general population. Pain 137(3):681–688. https://doi.org/10.1016/j.pain.2008.03.002 - DOI - PubMed
-
- Hall GC, Carroll D, McQuay HJ (2008) Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002–2005. BMC Fam Pract 9:26 Published 2008 May 6. https://doi.org/10.1186/1471-2296-9-26 - DOI - PubMed - PMC
-
- Koopman JS, Dieleman JP, Huygen FJ, de Mos M, Martin CG, Sturkenboom MC (2009) Incidence of facial pain in the general population. Pain 147(1–3):122–127. https://doi.org/10.1016/j.pain.2009.08.023 - DOI - PubMed
-
- Lee CH, Jang HY, Won HS, Kim JS, Kim YD (2021) Epidemiology of trigeminal neuralgia: an electronic population health data study in Korea. Korean J Pain 34(3):332–338. https://doi.org/10.3344/kjp.2021.34.3.332 - DOI - PubMed - PMC
-
- Svedung Wettervik T, Snel D, Kristiansson P, Ericson H, Abu Hamdeh S (2023) Incidence of trigeminal neuralgia: a population-based study in Central Sweden. Eur J Pain 27(5):580–587. https://doi.org/10.1002/ejp.2081 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical